This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

MediSwipe Inc. Announces Opinion On New Proposed Federal Legislation Regarding Medicinal Marijuana States And Provides Michigan Update

LOS ANGELES, April 15, 2013 (GLOBE NEWSWIRE) -- MediSwipe Inc. ( www.MediSwipe.com ) (OTCBB:MWIP), a patient security solutions and financial products company for the medicinal marijuana and health care industry, today announced information and a corporate opinion regarding a bill introduced in Congress late Friday which would pose a solution to the conflict between the federal government's marijuana prohibition and state laws that allow medical or recreational use.

California Republican Rep. Dana Rohrabacher said his bill, which has three Republican and three Democratic sponsors, would ensure that state laws on marijuana are respected by the federal government. The measure would seek to amend the Controlled Substances Act to make clear that individuals and businesses, including marijuana dispensaries, who comply with state marijuana laws are immune from federal prosecution. "This bipartisan bill represents a common-sense approach that establishes federal government respect for all states' marijuana laws," Rohrabacher said in a news release. "It does so by keeping the federal government out of the business of criminalizing marijuana activities in states that don't want it to be criminal."

Presently, eighteen states and the District of Columbia have medical marijuana laws, and two states, Washington and Colorado, last fall became the first to pass laws legalizing, taxing and regulating marijuana. Several other measures have also been introduced to change U.S. marijuana laws, including moves to legalize the industrial production of hemp and establish a hefty federal pot tax in states where it's legal. Republican Reps. Justin Amash of Michigan and Don Young of Alaska and Democratic Reps. Earl Blumenauer of Oregon, Steve Cohen of Tennessee and Jared Polis of Colorado co-sponsored Rohrabacher's bill.

The entire article by the Detroit Free Press may be read here:

http://www.freep.com/apps/pbcs.dll/article?AID=2013304120193

"It seems obvious that based on recent events in Michigan as well as Colorado and California, the need for one system or application that will allow patients to receive their medication directly from their caregiver, in a safe, secure manner while meeting the demands of each state and eventually the federal government, is now needed more than ever. The MediSwipe DMS will prove to be that solution, starting with scanning the patient record from the very beginning at patient certification, to the tracking of the purchase of medicine through our proprietary barcode system. We will soon be able expand to all legal jurisdictions as we continue to improve our software to meet the needs of each state requiring tracking and data from seed to plant to patient, to sale, and prove we are the most viable solution. Our software applications are set to cover the entire process of this industry, and will not be affected by a few dispensaries in one state that might have acted questionably. We are a patient and caregiver based solution. It is our goal, as always, to take the question marks out of the equation, and provide all the data necessary from seed to patient through specialized barcodes, biometrics and our patient portal for tracking of transactions moving toward a multi-jurisdictional model," stated B. Michael Friedman, CEO for MediSwipe.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs